Daniel Aeberli

Burgdorf, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

Journal: Annals of the rheumatic diseases

Published: February 19, 2026

Glucocorticoid-induced Osteoporosis; Epidemiology, Pathogenesis and Treatment

Glucocorticoid-induced Osteoporosis; Epidemiology, Pathogenesis and Treatment

Journal: Therapeutische Umschau. Revue therapeutique

Published: March 17, 2025

Bone health in patients with inflammatory bowel disease.

Bone health in patients with inflammatory bowel disease.

Journal: Swiss medical weekly

Published: June 14, 2024

Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial.

Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial.

Journal: PloS one

Published: October 26, 2022

Loss of LGR4/GPR48 causes severe neonatal salt wasting due to disrupted WNT signaling altering adrenal zonation.

Loss of LGR4/GPR48 causes severe neonatal salt wasting due to disrupted WNT signaling altering adrenal zonation.

Journal: The Journal of clinical investigation

Published: August 29, 2022

Expanding the p.(Arg85Trp) Variant-Specific Phenotype of HNF4A: Features of Glycogen Storage Disease, Liver Cirrhosis, Impaired Mitochondrial Function, and Glomerular Changes.

Expanding the p.(Arg85Trp) Variant-Specific Phenotype of HNF4A: Features of Glycogen Storage Disease, Liver Cirrhosis, Impaired Mitochondrial Function, and Glomerular Changes.

Journal: Molecular syndromology

Published: June 29, 2022

The effect of thyroid hormone therapy on muscle function, strength and mass in older adults with subclinical hypothyroidism-an ancillary study within two randomized placebo controlled trials.

The effect of thyroid hormone therapy on muscle function, strength and mass in older adults with subclinical hypothyroidism-an ancillary study within two randomized placebo controlled trials.

Journal: Age and ageing

Published: June 16, 2022

The effects of time-restricted eating and weight loss on bone metabolism and health: a 6-month randomized controlled trial.

The effects of time-restricted eating and weight loss on bone metabolism and health: a 6-month randomized controlled trial.

Journal: Obesity (Silver Spring, Md.)

Published: June 09, 2022

Correlation of muscle and bone parameters, daily function and participation in women with generalized joint hypermobility: a descriptive evaluation.

Correlation of muscle and bone parameters, daily function and participation in women with generalized joint hypermobility: a descriptive evaluation.

Journal: Journal of musculoskeletal & neuronal interactions

Published: March 02, 2022

Bone geometry in older adults with subclinical hypothyroidism upon levothyroxine therapy: A nested study within a randomized placebo controlled trial.

Bone geometry in older adults with subclinical hypothyroidism upon levothyroxine therapy: A nested study within a randomized placebo controlled trial.

Journal: Bone

Published: January 27, 2022

Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy.

Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy.

Journal: RMD open

Published: December 17, 2021

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study.

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study.

Journal: The Lancet. Rheumatology

Published: September 13, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026